These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors affecting the primary patency of native arteriovenous fistulas after ultrasound-guided percutaneous transluminal angioplasty. Xing X, Li Q, Yang Y, Wang Y, Zhan X, Zhang C, Xu G, He F. Ren Fail; 2023 Dec; 45(1):2233623. PubMed ID: 37488970 [Abstract] [Full Text] [Related]
4. Patency and factors related to patency after percutaneous transluminal angioplasty for inflow arterial stenosis in native arteriovenous fistula dysfunction: a single-center retrospective study. Chen B, Tu B, Lai Q, Chen L, Gao X, Zhou Y, Zhang X, Lv Q, Wan Z. Sci Rep; 2024 Sep 09; 14(1):21072. PubMed ID: 39256543 [Abstract] [Full Text] [Related]
5. The efficacy of percutaneous transluminal angioplasty and arteriovenous fistula reconstruction for immature arteriovenous fistula. Yu H, Chi Y, Wang B. BMC Nephrol; 2023 Oct 17; 24(1):304. PubMed ID: 37848833 [Abstract] [Full Text] [Related]
6. Efficacy of ultrasound-guided percutaneous transluminal angioplasty for arteriovenous fistula stenosis or occlusion at juxta-anastomosis: A 3-year follow-up cohort study. Gu H, Wan Z, Lai QQ, Zhou Y, Tu B, Hu B, Chen L, Gao XJ. J Vasc Surg; 2021 Jul 17; 74(1):217-224. PubMed ID: 33340700 [Abstract] [Full Text] [Related]
7. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients. Doi S, Masaki T, Shigemoto K, Harada S, Yorioka N. Ther Apher Dial; 2008 Jun 17; 12(3):232-6. PubMed ID: 18503701 [Abstract] [Full Text] [Related]
8. Comparison of percutaneous transluminal angioplasty and surgical revision after intraoperative dilatation with biliary tract probes for arteriovenous fistula stenosis at juxta-anastomosis. Luo F, Huang C, Yao G, Zhou J, Lu X. Vascular; 2024 Apr 17; 32(2):467-474. PubMed ID: 36384031 [Abstract] [Full Text] [Related]
14. Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty. Yap YS, Chi WC, Lin CH, Liu YC, Wu YW, Yang HY. Clin Exp Nephrol; 2021 Jan 17; 25(1):80-86. PubMed ID: 32852664 [Abstract] [Full Text] [Related]
15. Analysis of Factors Influencing Restenosis after Percutaneous Transluminal Angioplasty. Luo Q, Liu H, Yang Q. Blood Purif; 2022 Jan 17; 51(12):1031-1038. PubMed ID: 35504252 [Abstract] [Full Text] [Related]
16. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction. Granata A, Maccarrone R, Di Lullo L, Morale W, Battaglia GG, Di Nicolò P, Bellasi A, Pesce F, Khater E, Gesualdo L, Basile A, Gallieni M. J Vasc Access; 2021 Sep 17; 22(5):739-743. PubMed ID: 32715906 [Abstract] [Full Text] [Related]
19. Comparison of ultrasound features and lesion sites in dysfunctional arteriovenous fistula. Wang Y, Huang XM, Zhang Y, Li J, Li J, Ye Z, Peng Y, Zhang XJ, Tang N, Qiu WW, Xu L. Ren Fail; 2024 Dec 17; 46(1):2294148. PubMed ID: 38186351 [Abstract] [Full Text] [Related]
20. Sharp needle reconstructs peripheral outflow for patients with malfunctional arteriovenous fistula. Xu Y, Zhu SY, Li YM, Liu XX, Zhang H, Wang LF. Ren Fail; 2024 Dec 17; 46(1):2353351. PubMed ID: 38757707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]